 Julie Goodman
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 13 | 2024 | 407 | 3.980 |
Why?
| | Environmental Exposure | 16 | 2024 | 583 | 3.260 |
Why?
| | Occupational Exposure | 13 | 2025 | 357 | 3.260 |
Why?
| | Air Pollutants, Occupational | 6 | 2023 | 41 | 2.780 |
Why?
| | Asbestos | 5 | 2025 | 36 | 2.570 |
Why?
| | Air Pollution | 7 | 2024 | 315 | 2.490 |
Why?
| | Inhalation Exposure | 9 | 2021 | 103 | 2.350 |
Why?
| | Carcinogens | 6 | 2025 | 123 | 2.260 |
Why?
| | Particulate Matter | 9 | 2024 | 329 | 1.980 |
Why?
| | Phenols | 3 | 2024 | 106 | 1.980 |
Why?
| | Mesothelioma | 3 | 2025 | 52 | 1.960 |
Why?
| | Non-Nutritive Sweeteners | 2 | 2025 | 7 | 1.830 |
Why?
| | Ozone | 7 | 2021 | 116 | 1.820 |
Why?
| | Sweetening Agents | 2 | 2025 | 57 | 1.760 |
Why?
| | Toluene 2,4-Diisocyanate | 3 | 2018 | 3 | 1.470 |
Why?
| | Talc | 2 | 2024 | 9 | 1.470 |
Why?
| | Benzhydryl Compounds | 3 | 2024 | 81 | 1.410 |
Why?
| | Neoplasms | 6 | 2025 | 2946 | 1.370 |
Why?
| | Environmental Pollutants | 5 | 2021 | 142 | 1.280 |
Why?
| | Nickel | 4 | 2024 | 63 | 1.260 |
Why?
| | Asbestos, Amphibole | 4 | 2025 | 5 | 1.160 |
Why?
| | Lung Neoplasms | 5 | 2023 | 2679 | 0.990 |
Why?
| | Environmental Monitoring | 5 | 2023 | 347 | 0.980 |
Why?
| | 2,4-Dichlorophenoxyacetic Acid | 2 | 2017 | 14 | 0.950 |
Why?
| | Herbicides | 2 | 2017 | 27 | 0.930 |
Why?
| | Mutagens | 1 | 2025 | 27 | 0.910 |
Why?
| | Lymphoma, Non-Hodgkin | 2 | 2017 | 124 | 0.860 |
Why?
| | Asthma | 5 | 2018 | 1805 | 0.850 |
Why?
| | Food Safety | 1 | 2024 | 21 | 0.810 |
Why?
| | Risk Assessment | 15 | 2021 | 3784 | 0.800 |
Why?
| | Nitrogen Dioxide | 2 | 2017 | 45 | 0.790 |
Why?
| | Review Literature as Topic | 2 | 2021 | 53 | 0.780 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2218 | 0.660 |
Why?
| | Pesticide Residues | 1 | 2020 | 5 | 0.640 |
Why?
| | Pesticides | 1 | 2020 | 59 | 0.610 |
Why?
| | Lung | 9 | 2025 | 4141 | 0.590 |
Why?
| | Asbestos, Serpentine | 2 | 2021 | 5 | 0.580 |
Why?
| | Manganese | 2 | 2017 | 59 | 0.580 |
Why?
| | Humans | 52 | 2025 | 147293 | 0.570 |
Why?
| | Endocrine Disruptors | 3 | 2015 | 42 | 0.560 |
Why?
| | United States Environmental Protection Agency | 3 | 2015 | 28 | 0.560 |
Why?
| | Asthma, Occupational | 1 | 2018 | 3 | 0.560 |
Why?
| | Occupational Diseases | 2 | 2017 | 165 | 0.530 |
Why?
| | Food Additives | 1 | 2017 | 3 | 0.520 |
Why?
| | Benzoic Acid | 1 | 2017 | 9 | 0.520 |
Why?
| | Mortality | 2 | 2021 | 382 | 0.520 |
Why?
| | Welding | 1 | 2017 | 2 | 0.520 |
Why?
| | Respiratory Hypersensitivity | 1 | 2017 | 65 | 0.500 |
Why?
| | Hospitalization | 2 | 2018 | 2496 | 0.490 |
Why?
| | Research | 1 | 2020 | 434 | 0.480 |
Why?
| | Agriculture | 1 | 2017 | 94 | 0.470 |
Why?
| | Animals | 21 | 2025 | 38410 | 0.460 |
Why?
| | Aspartame | 2 | 2025 | 5 | 0.460 |
Why?
| | Saccharin | 2 | 2025 | 9 | 0.460 |
Why?
| | Thiazines | 2 | 2025 | 13 | 0.460 |
Why?
| | Reproduction | 1 | 2017 | 212 | 0.450 |
Why?
| | Sulfur Dioxide | 2 | 2015 | 12 | 0.430 |
Why?
| | Allergens | 1 | 2017 | 391 | 0.410 |
Why?
| | Science | 1 | 2015 | 55 | 0.410 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 599 | 0.400 |
Why?
| | Stomach Neoplasms | 1 | 2015 | 128 | 0.390 |
Why?
| | Rats | 6 | 2025 | 5613 | 0.380 |
Why?
| | Models, Theoretical | 1 | 2016 | 563 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2025 | 2030 | 0.360 |
Why?
| | No-Observed-Adverse-Effect Level | 3 | 2024 | 7 | 0.360 |
Why?
| | Models, Statistical | 2 | 2025 | 677 | 0.360 |
Why?
| | Atherosclerosis | 1 | 2015 | 411 | 0.340 |
Why?
| | Carcinogens, Environmental | 1 | 2010 | 14 | 0.330 |
Why?
| | Aluminum Silicates | 3 | 2015 | 17 | 0.320 |
Why?
| | Pleural Diseases | 3 | 2015 | 23 | 0.320 |
Why?
| | Mining | 3 | 2015 | 36 | 0.320 |
Why?
| | Dioxins | 1 | 2010 | 7 | 0.320 |
Why?
| | Toxicity Tests | 3 | 2016 | 53 | 0.300 |
Why?
| | Thyroid Hormones | 1 | 2010 | 69 | 0.300 |
Why?
| | Thyroid Gland | 1 | 2010 | 93 | 0.300 |
Why?
| | Biomarkers, Tumor | 1 | 2016 | 1339 | 0.290 |
Why?
| | Halogenated Diphenyl Ethers | 1 | 2009 | 7 | 0.290 |
Why?
| | Flame Retardants | 1 | 2009 | 10 | 0.290 |
Why?
| | Carcinogenicity Tests | 2 | 2024 | 13 | 0.280 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 648 | 0.270 |
Why?
| | Bronchial Hyperreactivity | 1 | 2009 | 104 | 0.270 |
Why?
| | Leydig Cell Tumor | 1 | 2007 | 8 | 0.270 |
Why?
| | Methyl Ethers | 1 | 2007 | 19 | 0.270 |
Why?
| | Prostatic Neoplasms | 1 | 2015 | 986 | 0.260 |
Why?
| | Respiratory Function Tests | 4 | 2015 | 545 | 0.250 |
Why?
| | Epidemiologic Studies | 2 | 2021 | 72 | 0.240 |
Why?
| | Testicular Neoplasms | 1 | 2007 | 111 | 0.240 |
Why?
| | Adenocarcinoma | 1 | 2013 | 928 | 0.240 |
Why?
| | Cyclamates | 1 | 2025 | 1 | 0.230 |
Why?
| | Diterpenes, Kaurane | 1 | 2025 | 1 | 0.230 |
Why?
| | Mineral Fibers | 1 | 2025 | 3 | 0.230 |
Why?
| | Behavior, Animal | 1 | 2009 | 530 | 0.220 |
Why?
| | Glucosides | 1 | 2025 | 56 | 0.220 |
Why?
| | Species Specificity | 3 | 2017 | 547 | 0.220 |
Why?
| | Paraffin Embedding | 1 | 2025 | 33 | 0.220 |
Why?
| | Sucrose | 1 | 2025 | 114 | 0.220 |
Why?
| | Formaldehyde | 1 | 2025 | 65 | 0.220 |
Why?
| | Survival Analysis | 1 | 2007 | 1386 | 0.210 |
Why?
| | SEER Program | 1 | 2025 | 232 | 0.200 |
Why?
| | Reflex | 1 | 2024 | 70 | 0.200 |
Why?
| | Vehicle Emissions | 1 | 2024 | 57 | 0.200 |
Why?
| | Silicates | 1 | 2023 | 13 | 0.190 |
Why?
| | Minerals | 1 | 2023 | 48 | 0.190 |
Why?
| | Public Health | 2 | 2020 | 577 | 0.180 |
Why?
| | Research Design | 2 | 2021 | 1157 | 0.180 |
Why?
| | United States | 6 | 2021 | 16313 | 0.180 |
Why?
| | Risk Factors | 4 | 2023 | 11017 | 0.180 |
Why?
| | Brain | 2 | 2017 | 3009 | 0.170 |
Why?
| | Air Pollution, Indoor | 1 | 2023 | 171 | 0.160 |
Why?
| | Dietary Exposure | 1 | 2020 | 9 | 0.160 |
Why?
| | Guidelines as Topic | 2 | 2020 | 268 | 0.160 |
Why?
| | Iron | 1 | 2023 | 361 | 0.160 |
Why?
| | International Agencies | 1 | 2020 | 30 | 0.160 |
Why?
| | Mice | 4 | 2024 | 18491 | 0.140 |
Why?
| | Threshold Limit Values | 1 | 2018 | 1 | 0.140 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 748 | 0.140 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 708 | 0.130 |
Why?
| | Diet | 1 | 2025 | 1284 | 0.130 |
Why?
| | Recommended Dietary Allowances | 1 | 2017 | 16 | 0.130 |
Why?
| | Salts | 1 | 2017 | 35 | 0.130 |
Why?
| | Administration, Cutaneous | 1 | 2017 | 127 | 0.130 |
Why?
| | Maximum Allowable Concentration | 1 | 2017 | 16 | 0.130 |
Why?
| | Female | 8 | 2025 | 80076 | 0.130 |
Why?
| | Uncertainty | 1 | 2017 | 146 | 0.120 |
Why?
| | Montana | 1 | 2016 | 18 | 0.120 |
Why?
| | Epidemiologic Methods | 1 | 2016 | 91 | 0.120 |
Why?
| | Legislation, Drug | 1 | 2017 | 73 | 0.120 |
Why?
| | Texas | 1 | 2017 | 278 | 0.120 |
Why?
| | Mutagenesis | 1 | 2016 | 196 | 0.110 |
Why?
| | Male | 10 | 2025 | 73950 | 0.110 |
Why?
| | Data Accuracy | 1 | 2015 | 65 | 0.110 |
Why?
| | California | 1 | 2017 | 477 | 0.110 |
Why?
| | Sulfuric Acids | 1 | 2015 | 8 | 0.110 |
Why?
| | Occupational Health | 1 | 2018 | 213 | 0.110 |
Why?
| | Risk | 1 | 2017 | 927 | 0.110 |
Why?
| | Models, Animal | 1 | 2016 | 394 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2973 | 0.100 |
Why?
| | DNA Repair | 1 | 2016 | 256 | 0.100 |
Why?
| | Electrical Equipment and Supplies | 1 | 2013 | 8 | 0.100 |
Why?
| | DNA Damage | 1 | 2016 | 440 | 0.100 |
Why?
| | Cardiovascular System | 1 | 2015 | 139 | 0.100 |
Why?
| | Phenylenediamines | 1 | 2013 | 14 | 0.100 |
Why?
| | Europe | 1 | 2013 | 426 | 0.090 |
Why?
| | Decision Making | 1 | 2020 | 994 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3448 | 0.090 |
Why?
| | Time Factors | 2 | 2015 | 7173 | 0.090 |
Why?
| | DNA Methylation | 1 | 2016 | 722 | 0.080 |
Why?
| | Data Interpretation, Statistical | 2 | 2015 | 369 | 0.080 |
Why?
| | Biological Availability | 1 | 2010 | 146 | 0.080 |
Why?
| | Administration, Oral | 1 | 2013 | 874 | 0.080 |
Why?
| | Polychlorinated Biphenyls | 1 | 2010 | 11 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1457 | 0.080 |
Why?
| | Benzofurans | 1 | 2010 | 26 | 0.080 |
Why?
| | Nitric Oxide | 1 | 2015 | 892 | 0.080 |
Why?
| | Thyrotropin | 1 | 2010 | 120 | 0.080 |
Why?
| | Neurotoxicity Syndromes | 1 | 2009 | 40 | 0.070 |
Why?
| | Young Adult | 2 | 2017 | 14437 | 0.070 |
Why?
| | Respiratory Tract Diseases | 1 | 2010 | 178 | 0.070 |
Why?
| | Reference Standards | 1 | 2009 | 177 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2920 | 0.070 |
Why?
| | Solubility | 1 | 2009 | 240 | 0.070 |
Why?
| | Respiratory Mucosa | 1 | 2010 | 324 | 0.070 |
Why?
| | Middle Aged | 4 | 2025 | 36821 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2627 | 0.060 |
Why?
| | Regression Analysis | 1 | 2009 | 1003 | 0.060 |
Why?
| | Adolescent | 2 | 2017 | 22825 | 0.060 |
Why?
| | Nicotine | 1 | 2009 | 336 | 0.060 |
Why?
| | Animals, Newborn | 1 | 2009 | 914 | 0.060 |
Why?
| | Cohort Studies | 2 | 2024 | 6099 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2025 | 37 | 0.060 |
Why?
| | Switzerland | 1 | 2025 | 46 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2416 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2012 | 4169 | 0.050 |
Why?
| | Motor Activity | 1 | 2009 | 719 | 0.050 |
Why?
| | United Kingdom | 1 | 2025 | 391 | 0.050 |
Why?
| | Retrospective Studies | 2 | 2020 | 17560 | 0.050 |
Why?
| | Aged | 3 | 2025 | 26514 | 0.050 |
Why?
| | Adult | 2 | 2017 | 41405 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2542 | 0.040 |
Why?
| | Child, Preschool | 1 | 2017 | 12016 | 0.040 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2020 | 167 | 0.040 |
Why?
| | Inflammasomes | 1 | 2020 | 145 | 0.030 |
Why?
| | Biomarkers | 1 | 2010 | 4351 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2010 | 6543 | 0.030 |
Why?
| | Child | 1 | 2017 | 22979 | 0.030 |
Why?
| | Bias | 1 | 2015 | 201 | 0.030 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2014 | 78 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1844 | 0.020 |
Why?
| | World Health Organization | 1 | 2014 | 105 | 0.020 |
Why?
| | Spirometry | 1 | 2014 | 235 | 0.020 |
Why?
| | Benchmarking | 1 | 2009 | 194 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 800 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 3149 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2791 | 0.010 |
Why?
|
|
Goodman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|